Skip to main content
SpringerLink
Log in

Drug resistance and DNA repair in leukaemia

  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

Most cytotoxic agents exert their action via damage of DNA. Therefore, the repair of such lesions is of major importance for the sensitivity of malignant cells to chemotherapeutic agents. The underlying mechanisms of various DNA repair pathways have extensively been studied in yeast, bacteria and mammalian cells. Sensitive and drug resistant cancer cell lines have provided models for analysis of the contribution of DNA repair to chemosensitivity. However, the validity of results obtained by laboratory experiments with regard to the clinical situation is limited. In both acute and chronic leukaemias, the emergence of drug resistant cells is a major cause for treatment failure. Recently, assays have become available to measure cellular DNA repair capacity in clinical specimens at the single-cell level. Application of these assays to isolated lymphocytes from patients with chronic lymphatic leukaemia (CLL) revealed large interindividual differences in DNA repair rates. Accelerated O6-ethylguanine elimination from DNA and faster processing of repair-induced single-strand breaks were found in CLL lymphocytes from patients nonresponsive to chemotherapy with alkylating agents compared to untreated or treated sensitive patients. Moreover, modulators of DNA repair with different target mechanisms were identified which also influence the sensitivity of cancer cells to alkylating agents. In this article, we review the current knowledge about the contribution of DNA repair to drug resistance in human leukaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland R, Koi M, Fishel R and Howell SB (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56: 3087-3090.

    CAS  Google Scholar 

  • Andersson BS, Mroue M, Britten RA and Murray D (1994) The role of DNA damage in the resistance of human chronic myleoid leukemia cells to cyclophosphamide analogues. Cancer Res 54: 5394-5400.

    CAS  Google Scholar 

  • Barret JM, Calsou P and Salles B (1995) Deficient nucleotide excision repair activity in protein extracts from normal human lymphocytes. Carcinogenesis 16: 1611-1616.

    CAS  Google Scholar 

  • Barret JM, Calsou P, Laurent G and Salles B (1996) DNA repair activity in protein extracts of fresh human malignant lymphoid cells. Mol Pharmacol 49: 766-771.

    CAS  Google Scholar 

  • Beck T, Grogan TM, illman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreef M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP and Weinstein R (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations. Cancer Res 56: 3010-3020.

    CAS  Google Scholar 

  • Begleiter A, Goldenberg GJ, Anhalt CD, Lee K, Mowat MR, Israels LG and Johnston JB (1991) Mechanisms of resistance to chlorambucil in chronic lymphocytic leukaemia. Leuk Res 15: 1019-1027.

    Article  CAS  Google Scholar 

  • Beketic-Oreskovic L and Osmak (1995) Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Cancer Chemother Pharmacol 35: 327-333.

    CAS  Google Scholar 

  • Bentley P, Thomas A and Thomas J (1996) Failure to induce resistance to cytotoxic drugs in normal lymphocytes. Leuk Res 20: 645-648.

    Article  CAS  Google Scholar 

  • Boulton S, Pemberton LC, Porteous JK, Curtin NJ, Griffin RJ, Golding BT and Durkacz BW (1995) Potentiation of temozolomideinduced cytotoxicity: A comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors. Br J Cancer 72: 849-856.

    CAS  Google Scholar 

  • Bramson J, Prévost J, Malapetsa A, Noe AJ, Poirier GG, DesNoyers S, Alaoui-Jamali M and Panasci L (1993) Poly(ADP-ribose) polymerase can bind melphalan damaged DNA. Cancer Res 53: 5370-5373.

    CAS  Google Scholar 

  • Bramson J, McQuillan A and Panasci LC (1995) DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance. Cancer Lett 90: 139-148.

    Article  CAS  Google Scholar 

  • Buschfort C, Müller MR, Seeber S, Rajewsky MF and Thomale J (1997) DNA excision repair profiles of normal and leukemic human lymphocytes: Functional analysis at the single-cell level. Cancer Res 57: 651-658.

    CAS  Google Scholar 

  • Cappelli E, Redaelli A, Rivano ME, Abbondandolo A and Frosina G (1995) Repair of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoureainduced damage by mammalian cell extracts. Carcinogenesis 16: 2267-2270.

    CAS  Google Scholar 

  • Chaney SG and Sancar A (1996) DNA repair: Enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 88: 1346-1360.

    CAS  Google Scholar 

  • Cleaver JE, Charles WC, McDowell ML, Sadinsky WJ and Mitchell DL (1995) Overexpression of the XPA repair gene increases resistance to ultraviolet radiation in human cells by selective repair of DNA damage. Cancer Res 55: 6152-6160.

    CAS  Google Scholar 

  • Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654.

    CAS  Google Scholar 

  • Cunningham RP (1997) DNA glycosylases. Mutat Res 383: 189-196.

    CAS  Google Scholar 

  • Dabholkar M, Bostick-Bruton F, Weber V, Egwuagu C, Bohr VA and Reed E (1993) Expression of excision repair genes in nonmalignant bone marrow from cancer patients. Mutat Res 293: 151-160.

    CAS  Google Scholar 

  • Eder JP Jr, Chan VTW, Ng SW, Rizwi NA, Zacharoulis S, Teicher BA and Schnipper LE (1995) DNA topoisomerase II alpha expression is associated with alkylating agent. Cancer Res 55: 6109-6116.

    CAS  Google Scholar 

  • Engelbergs J, Thomale J, Galhoff A and Rajewsky MF (1998) Fast repair of O6-ethyl, but not O6-methylguanine, in transcribed genes prevents mutation of H-rasin rat mammary tumorigenesis induced by ethyl-in place of methylnitrosourea. Proc Natl Acad Sci USA 95: 1635-1640.

    Article  CAS  Google Scholar 

  • Engelward BP, Dreslin A, Christensen J, Huszar D, Kurahara C and Samson L (1996) Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J 15: 945-952.

    CAS  Google Scholar 

  • Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K and Pirker R (1997) Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome. Clin Cancer Res 3: 1419-1425.

    CAS  Google Scholar 

  • Geleziunas R, McQuillan A, Malapetsa A, Hutchinson M and Kopriva D (1991) Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukaemia resistant to nitrogen mustards. J Natl Cancer Inst 83: 557-564.

    CAS  Google Scholar 

  • Gerson SL, Trey JE, Miller K and Berger NA (1986) Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 7: 745-749.

    CAS  Google Scholar 

  • Gerson SL, Miller K and Berger NA (1985) O6-alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest 76: 2106-2114.

    Article  CAS  Google Scholar 

  • Goth R and Rajewsky MF (1974) Persistence of O6-ethylguanine in rat-brain DNA: Correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc Natl Acad Sci USA 71: 639-643.

    Article  CAS  Google Scholar 

  • Griffin RJ, Curtin NJ, Newell DR, Golding BT, Durkacz BW and Calvert AH (1995) The role of inhibitors of poly(ADPribose) polymerase as resistance-modifying agents in cancer therapy. Biochimie 77: 408-422.

    Article  CAS  Google Scholar 

  • Ibeanu G, Hartenstein B, Dunn WC, Chang LY, Hofmann E, Coquerelle T, Mitra S and Kaina B (1992) Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis 13: 1989-1995.

    CAS  Google Scholar 

  • Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF and Hamilton TC (1994) Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and-resistant human ovarian cancer cells. Cancer Res 54: 5911-5916.

    CAS  Google Scholar 

  • Joncourt F, Oberli A, Redmond SMS, Fey MF, Tobler A, Margison GP, Gratwohl A, Buser K and Cerny T (1993) Cytostatic drug resistance: Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and Pglycoprotein in adult patients with leukaemia. Br J Haematol 85: 103-111.

    CAS  Google Scholar 

  • Juliano R and Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162.

    Article  CAS  Google Scholar 

  • Karran P and Hampson R (1996) Genomic instability and tolerance to alkylating agents. Cancer Surv 28: 69-85.

    CAS  Google Scholar 

  • Kolodner RD (1995) Mismatch repair: Mechanisms and relationship to cancer susceptibility. TIBS 20: 397-401.

    CAS  Google Scholar 

  • Li L, Liu XM, Glassman AB, Keating MJ, Stros M, Plunkett W and Yang LY (1997) Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res 57: 1487-1494.

    CAS  Google Scholar 

  • Lindahl T, Karran P and Wood RD (1997) DNA excision repair pathways. Curr Opin Genet Dev 7: 158-169.

    Article  CAS  Google Scholar 

  • List AF (1997) Non-P-glycoprotein drug export mechanisms of multidrug resistance. Semin Hematol 34(Suppl 5) 1: 20-24.

    CAS  Google Scholar 

  • Liu L, Markowitz S and Gerson SL (1996) Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res 56: 5375-5379.

    CAS  Google Scholar 

  • Modrich P (1994) Mismatch repair, genetic stability, and cancer. Science 266: 1959-1960.

    CAS  Google Scholar 

  • Müller MR, Thomale J, Lensing C, Rajewsky MF and Seeber S (1993) Chemosensitisation to alkylating agents by pentoxifylline, O6-benzylguanine and ethacrynic acid in haematological malignancies. Anticancer Res 13: 2155-2160.

    Google Scholar 

  • Müller MR, Seiler F, Thomale J, Buschfort C, Rajewsky MF and Seeber S (1994) Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: Relation to chemosensitivity in vitroand treatment outcome. Cancer Res 54: 4524-4531.

    Google Scholar 

  • Müller MR, Buschfort C, Thomale J, Lensing C, Rajewsky MF and Seeber S (1997) DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia. Clin Cancer Res 3: 2055-2061.

    Google Scholar 

  • Olive PL, Wlodek D and Banáth JP (1991) DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res 51: 4671-4676.

    CAS  Google Scholar 

  • Panasci L, Henderson D, Torres-Garcia SJ, Skalski V, Caplan S and Hutchinson M (1988) Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia. Cancer Res 48: 1972-1976.

    CAS  Google Scholar 

  • Pegg AE (1990) Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating agents. Cancer Res 50: 6119-6129.

    CAS  Google Scholar 

  • Petersen LN, Mamenta EL, Stevnsner T, Chaney SG and Bohr VA (1996) Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity. Carcinogenesis 17: 2597-2602.

    CAS  Google Scholar 

  • Pieper RO, Futscher BW, Dong Q and Erickson LC (1991) Effects of streptozotocin/bis-chlorethylnitrosourea combination therapy on O6-methylguanine-DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Cancer Res 51: 1581-1585.

    CAS  Google Scholar 

  • Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, Ludwig H and Lechner K (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83: 708-712.

    CAS  Google Scholar 

  • Preuss I, Thust R and Kaina B (1996) Protective effect of O6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int J Cancer 65: 506-512.

    Article  CAS  Google Scholar 

  • Purnell MR and Whish WJD (1980) Novel inhibitors of poly(ADPribose) synthetase. Biochem J 185: 775-777.

    CAS  Google Scholar 

  • Sancar A (1994) Mechanisms of DNA excision repair. Science 266: 1954-1956.

    CAS  Google Scholar 

  • Sancar A (1995) DNA repair in humans. Annu Rev Genet 29: 69-105.

    Article  CAS  Google Scholar 

  • Sargent JM, Elgie AW, Williamson CJ and Taylor CG (1996) Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours. Br J Cancer 74: 1730-1733.

    CAS  Google Scholar 

  • Seiler F, Kirstein U, Eberle G, Hochleitner K and Rajewsky MF (1993) Quantification of specific DNA O-alkylation products in individual cells by monoclonal antibodies and digital imaging of intensified nuclear fluorescence. Carcinogenesis 9: 1907-1913.

    Google Scholar 

  • Silber JR, Blank A, Bobola MS, Mueller BA, Kolstoe DD, Ojemann GA and Berger MS (1996) Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc Natl Acad Sci USA 93: 6941-6946.

    Article  CAS  Google Scholar 

  • Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S and Graziani, G (1997) Inhibition of O6-alkylguanine-DNA alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide. Mol Pharmacol 52: 249-258.

    CAS  Google Scholar 

  • Terheggen PMAB, Emondt JY, Floot BGJ, Dijkman R, Schrier PI, den Engelse L and Begg AC (1990) Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum. Cancer Res 50: 3556-3561.

    CAS  Google Scholar 

  • Thomale J, Seiler F,Müller MR, Seeber S and Rajewsky MF (1994) Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: Analysis at the single-cell level. Br J Cancer 69: 698-705.

    CAS  Google Scholar 

  • Torres-Garcia SJ, Cousineau L, Caplan S and Panasci L (1989) Correlation of resistance to nitrogen mustards in chronic lymphocytic leukaemia with enhanced removal of melphalan-induced cross-links. Biochem Pharmacol 38: 3122-3123.

    Article  CAS  Google Scholar 

  • Valkov NI and Sullivan DM (1997) Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma and multiple myeloma. Semin Hematol 34(Suppl. 5) 1: 48-62.

    CAS  Google Scholar 

  • Vendrik CPJ, Fichtinger-Schepman AMJ, van Dijk-Knijnenburg, de Jong WH, van der Minnen ACE, de Groot G, Berends GF and Steerenberg PA (1997) Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum(II) does not correlate with the platination level or with the formation or removal of DNA adducts. Cancer Chemother Pharmacol 39: 479-485.

    Article  CAS  Google Scholar 

  • Waldstein E, Cao E, Bender M and Setlow RB (1982) Abilities of extracts of human lymphocytes to remove O6-methylguanine from DNA. Mutat Res 95: 406-416.

    Google Scholar 

  • Walker IG and Reid BD (1971) Caffeine potentiation of the lethal action of alkylating agents on L-cells. Mutat Res 12: 101-104.

    CAS  Google Scholar 

  • Wang G, Weiss C, Sheng P and Bresnick E (1996) Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents. Biochem Pharmacol 51: 1221-1228.

    Article  CAS  Google Scholar 

  • Yang LY, Li L, Keating MJ and Plunkett W (1995) Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. Mol Pharmacol 47: 1072-1079.

    CAS  Google Scholar 

  • Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Roy R, Mitra S and Alaoui-Jamali MA (1995) Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bifunctional alkylating agents. Mutat Res 337: 179-189.

    CAS  Google Scholar 

Download references

Authors
  1. Mark R. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Thomale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manfred F. Rajewsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Siegfried Seeber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, M.R., Thomale, J., Rajewsky, M.F. et al. Drug resistance and DNA repair in leukaemia. Cytotechnology 27, 175–185 (1998). https://doi.org/10.1023/A:1008064804678

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008064804678

Search

Navigation